Tube Investments of India Ltd
Tube Investments of India Ltd Q2 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Q2 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Core standalone business expected to grow revenues by ~10% with PBT growth of 12-15% in FY2026. Standalone business revenue growth expected around 10%; PBT growth projected between 12%-15%. - TI Medical targeted for 25% CAGR growth including new vertical additions. - Engineering division volume growth approx.
From Tube Investments of India Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Core standalone business expected to grow revenues by ~10% with PBT growth of 12-15% in FY2026.
- Capex of Rs. 300-400 Crores planned for base business expansion.
- Additional Rs. 300-400 Crores capex targeted for growth initiatives in TI Medical, 3xper, and related ventures.
- Rs. 200-300 Crores earmarked for potential M&A or new business lines to boost growth.
- TI Medical aims for a 25% CAGR growth, adding new verticals beyond sutures.
- EV segment: 50%+ market share in electric trucks pan-India with product launches including swap technology and new variants to drive volume growth.
- Three-wheeler EV volumes expected to pick up from Q4 after product improvements.
- Engineering division volume growth about 10% YoY; capacity utilization at 80-85%, with new plants increasing capacity for 1-2 years.
- Overall long-term thesis intact, targeting sustained double-digit growth over 5-10 years.
Profitability & Margins
See what Tube Investments of India Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- **Next Year Capex Plans:**
- - Rs. 300-400 Crores for standalone (base) business expansion.
- - Rs. 300-400 Crores planned for growth areas including TI Medical (Greenfield) and 3xper Innoventure.
- - Additional Rs. 200-300 Crores may be allocated for M&A activities in related new lines of business.
- - Investment in TI Clean Mobility to be decided later in the year.
- **3xper Innoventure:**
- - Total planned investment of Rs. 300 Crores.
- - Rs. 200 Crores invested till last year.
- - Rs. 50 Crores invested this year (Q1 and Q2).
- - Remaining Rs. 50 Crores to be deployed this year.
- **TI Medical:**
- - Investments focused on new medical lines beyond sutures.
- - Growth driven by operational and capital investments.
- **Strategic Focus:**
- - Capital deployment aligned with long-term growth and profitability targets.
- - Emphasis on both organic expansion and inorganic growth through M&A.
Fundraising & Capital Structure
See what Tube Investments of India Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Engineering division is running at 80% to 85% capacity utilization, with new plants at Nasik and Phaltan starting operations recently, providing capacity for the next 1-2 years.
- Railway business has a strong order book with expected revenue growth starting Q4 FY2026, though there is a one-quarter delay due to other suppliers’ supply chain readiness; TI’s readiness is confirmed.
- TI Clean Mobility's electric vehicle segment has existing orders with 300+ trucks already running, and new product launches planned, indicating a healthy order pipeline.
- Medical devices and 3xper have ongoing investments with planned capex and expected growth, indicating committed orderbook and work-in-progress.
- No specific quantitative orderbook figures disclosed, but operational and strategic readiness points to strong pending orders and order inflow across key segments.
Tube Investments of India Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹6.2K Cr, net profit ₹234 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Tube Investments of India Ltd's management said in earlier quarters
Others in Auto Components this season
- Kross Ltd (Q2 FY26)
Kross Limited experienced flat revenue growth post-IPO, with H1 FY26 revenues declining 5.3% YoY, reflecting a subdued industry environment. Key concall…
- Emerald Tyre Manufacturers Ltd (Q2 FY26)
Confident of reaching ₹300 crore by FY27, with possibility of ₹350 crore if market conditions improve. Key concall takeaways from Emerald Tyre Manufacturers…
- JTEKT India Ltd (Q2 FY26)
Sales growth in the first half of FY 25-26 was 5.6%, outperforming the passenger vehicle market growth of 1.6%. Key concall takeaways from JTEKT India Ltd's Q2…
- Bosch Ltd (Q2 FY26)
Revenue for April-September 2025 grew 10% over previous year; EBITDA grew 16.3% in the same period, driven by favorable product mix and lower material cost…
Frequently Asked Questions
What were Tube Investments of India Ltd Q2 FY26 results?
Core standalone business expected to grow revenues by ~10% with PBT growth of 12-15% in FY2026. Standalone business revenue growth expected around 10%; PBT growth projected between 12%-15%. - TI Medical targeted for 25% CAGR growth including new vertical additions. - Engineering division volume growth approx.
What is Tube Investments of India Ltd share price analysis?
Tube Investments of India Ltd currently shows a neutral. The stock trades at a P/E of 84.4 with a market cap of ₹52,913 Cr. Investors should review the full earnings analysis for detailed insights.
Is Tube Investments of India Ltd planning capital expenditure?
Next Year Capex Plans:** - Rs.
Keep Tube Investments of India Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.